WAY-181187 has demonstrated preclinical efficacy in rodent models of depression, anxiety, and notably obsessive-compulsive disorder, though it has also been shown to impair cognition and memory.
WAY-181,187 je efikasan u modelima na glodarima za depresiju, anksioznost, i opsesivno-kompulzivni poremećaj, mada je pokazano do umanjuje kogniciju i memoriju.